搜尋結果
Will Amgen Stock Continue To See Higher Levels Driven By Its Obesity Injection?
Forbes· 16 小時前Firstly, let us look at Amgen’s stock performance. AMGN stock has shown gains of 30% from ...
Is Pfizer Stock Fully Valued At $28?
Forbes· 2 日前Pfizer (NYSE: PFE) reported its Q1 results last week, with revenues and earnings beating the ...
Is 3M Stock Appropriately Priced Around $95?
Forbes· 7 日前3M (NYSE: MMM) recently reported its Q1’24 results, with revenues and earnings beating the ...
Up 10% This Year, Does Johnson Controls Stock Still Have Room To Grow?
Forbes· 16 小時前Johnson Controls stock (NYSE: JCI) reported its Q2 fiscal 2024 results last week (fiscal ends ...
Gaining 20% This Year, Will Tripadvisor Stock Rally Further After Q1 Results?
Forbes· 2 日前It should be noted that LTRPA owns 21.1% of Tripadvisors’ shares outstanding and TRIP’s stock ...
With The Stock Flat This Year, Will Q3 Results Drive News Corp’s Stock Higher?
Forbes· 16 小時前We expect NWSA’s stock to see little to no movement with revenues and earnings matching ...
Will Colgate-Palmolive Stock See Higher Levels After Over A 15% Rise This Year?
Forbes· 16 小時前(NYSE: CL) reported its Q1 results on April 26, with revenues and earnings above the street estimates. Despite its upbeat ...
Zoom Stock May Rise 26% On Company's Bet That AI Can Boost Growth
Forbes· 1 日前Shares of Zoom Video have lost 89% of the peak value they reached in October 2020. The last ...
Here’s Why YouthForia’s Foundation Is Facing Criticism For Allegedly Being ‘Tar In A Bottle’
Forbes· 6 日前Makeup brand YouthForia is facing criticism from beauty influencers for releasing a foundation ...
Can Vitamin D Improve Cancer Immunotherapy?
Forbes· 16 小時前Whether by rays of sun or through capsules, it’s important for everyone to get their daily dose ...